GemPharmatech

Happy holidays from GemPharmatech! Thank you to all of our partners and colleagues who have made 2025 such a special year. As much as we like to celebrate our successes, what we are most grateful for is our expanding team of brilliant and amazing people. Hope the rest of our team across the US and abroad are all taking a well deserved moment of rest and relaxation before the new year! Lawrence Chongbo Xu, Jun Wang, Brandy Wilkinson, Trenton Wilder, Andrea Torres, Tyler Rader, John Jackson, Mark Johnson #HappyHolidays

𝐏𝐨𝐬𝐭𝐞𝐫 𝐍𝐨𝐰 𝐀𝐯𝐚𝐢𝐥𝐚𝐛𝐥𝐞 𝐟𝐨𝐫 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝. Download our poster from the American College of Rheumatology Convergence 2024: Phenotypic Validation of Humanized IgA1 and CD89 Transgenic Mice as a Model for IgA Nephropathy-Like Autoimmune Disease! 👇 Click here 🖱️ https://buff.ly/41wCaCm The etiology of IgA nephropathy (IgAN) remains only partly understood, but the presence of IgA antibodies together with the myeloid IgA receptor FcαRI/CD89 complexes in the circulation of patients is considered a specific pathogenic factor for mesangial deposition. The absence of a CD89 ortholog in rodents, coupled with the differences in the IgA systems between humans and mice, further hinders exploration of IgAN pathogenesis... #autoimmune #ACR24 #Convergence24 #MouseModels

GemPharmatech is proud to announce that Dr. Andrew P. has joined our sales team as Executive Director of Commercial Strategy in Europe! We encourage all of our researcher and scientist friends to connect with Andrew and join us in welcoming him aboard. Dr. Puca has extensive experience in the pharmaceutical industry working in pre-clinical and clinical roles at several contract research organizations, and will be vital in elevating GemPharmatech's presence across the region. In addition to his business acumen, Dr. Puca’s commitment to improving human health and his passion for developing translational models in various therapeutic areas will be crucial as we continue the rapid expansion of our preclinical capabilities. Dr. Puca received his Ph.D. in Medical Biotechnology from the Università degli Studi di Siena, Italy where he specialized in cancer and stem cell biology. #NewHire #Announcement #GemPharmatech

GemPharmatech is growing! We are currently seeking a candidate to join our Business Development team responsible for the Midwestern US Region. If you are an experienced and passionate sales rep with experience selling into pharma and biotechs, apply below! View the job listing here: https://lnkd.in/dAgHvJCw Make sure to follow our page to stay up to date on all our job postings! #LifeScienceJobs #CRO #GemPharmatech #SanDiegoBusiness #SanDiegoLifescience

𝐏𝐨𝐬𝐭𝐞𝐫 𝐍𝐨𝐰 𝐀𝐯𝐚𝐢𝐥𝐚𝐛𝐥𝐞 𝐟𝐨𝐫 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝. Download our poster from the American College of Rheumatology Convergence 2024: Humanized BAFF Transgenic Mice Develop Autoimmune Manifestations! 👇 Click here 🖱️ https://buff.ly/41wCaCm B-cell-activating factor (BAFF) plays a critical role in B cell survival, and its elevated expression can contribute to the presence of autoreactive B cells, potentially leading to autoimmune conditions like Systemic Lupus Erythematosus (SLE). To deepen our understanding of these mechanisms, GemPharmatech developed a transgenic mouse model featuring human BAFF overexpression. #autoimmune #ACR24 #Convergence24 #MouseModels

𝐖𝐞 𝐚𝐫𝐞 𝐜𝐨𝐧𝐬𝐭𝐚𝐧𝐭𝐥𝐲 𝐮𝐩𝐝𝐚𝐭𝐢𝐧𝐠 𝐨𝐮𝐫 𝐜𝐨𝐥𝐥𝐞𝐜𝐭𝐢𝐨𝐧 𝐨𝐟 𝐠𝐞𝐧𝐞𝐭𝐢𝐜𝐚𝐥𝐥𝐲 𝐞𝐧𝐠𝐢𝐧𝐞𝐞𝐫𝐞𝐝 𝐦𝐨𝐮𝐬𝐞 𝐦𝐨𝐝𝐞𝐥𝐬 𝐭𝐨 𝐛𝐞𝐭𝐭𝐞𝐫 𝐬𝐞𝐫𝐯𝐞 𝐭𝐡𝐞 𝐬𝐜𝐢𝐞𝐧𝐭𝐢𝐟𝐢𝐜 𝐜𝐨𝐦𝐦𝐮𝐧𝐢𝐭𝐲. Take a look at the newly released models we have to round out the end of the year and support: #Autoimmune #ImmunoOncology #Metabolic #Neuroscience and #RareDisease research! As always, search for your target gene of interest right from our homepage: https://lnkd.in/g8yF4kNT

👏 Thank you to everyone who attended the Tumour Models London Summit yesterday! Dr. Hongyan Sun’s insightful presentation on "Development and Application of Innovative Models for Immunotherapy: Common Issues and Solutions in Non-clinical Evaluation" was a true highlight, sparking engaging discussions and offering valuable takeaways. If you’re interested in exploring more, be sure to connect with Vannah Wan and Cassie Zhao! #TumourModels #LifeScience #Innovation #Research #MouseModels #Biotech #ResearchModels

🔈 Day 2 at JSI2024 A huge thank you to everyone who stopped by our booth or connected with our team. Don't miss today's 𝐩𝐨𝐬𝐭𝐞𝐫 𝐩𝐫𝐞𝐬𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧 by Dr. Juan Liang from 4:40 PM to 5:25 PM. Connect with Ellen Liu and Choiy Yin for more information. We look forward to seeing you! #JSI2024 #BiotechInnovation #Biotech #DrugDevelopment #MouseModels #CRO #LifeScience #Biotechnology #ResearchModels

🐁 We’re excited to announce that we are an official partner of the 𝐓𝐮𝐦𝐨𝐮𝐫 𝐌𝐨𝐝𝐞𝐥𝐬 𝐋𝐨𝐧𝐝𝐨𝐧 𝐒𝐮𝐦𝐦𝐢𝐭, taking place on 4th - 5th December 2024 in London, UK! Join us for two action-packed days of cutting-edge insights and groundbreaking content at this free-to-attend event for drug developers. Dr. Hongyan Sun will be delivering a key presentation titled: "𝐃𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭 𝐚𝐧𝐝 𝐀𝐩𝐩𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧 𝐨𝐟 𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐯𝐞 𝐌𝐨𝐝𝐞𝐥𝐬 𝐟𝐨𝐫 𝐈𝐦𝐦𝐮𝐧𝐨𝐭𝐡𝐞𝐫𝐚𝐩𝐲: 𝐍𝐨𝐧-𝐜𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐒𝐨𝐥𝐮𝐭𝐢𝐨𝐧𝐬 𝐟𝐨𝐫 𝐕𝐚𝐫𝐢𝐨𝐮𝐬 𝐓𝐡𝐞𝐫𝐚𝐩𝐞𝐮𝐭𝐢𝐜𝐬" 🗓️ December 4th, 2:30 PM - 3:00 PM Don’t miss out on this fantastic opportunity for engaging discussions! Feel free to connect with Cassie Zhao and Vannah Wan for more details. 🔍 We look forward to seeing you there! Learn more：https://lnkd.in/gwKZnmkJ #TumourModels #BiotechInnovation #Biotech #DrugDevelopment #MouseModels #CRO #LifeScience #Biotechnology #ResearchModels

👏 Day 2 at MBSJ 2024 in Fukuoka! A huge thank you to everyone who met with our team yesterday! Please be sure to reach out to Ellen Liu and Choiy Yin, your primary contacts for all inquiries related to mouse models and preclinical services. 🔍 Join us for our poster presentation: Chromosome 1 Substitution Strains, a New Resource for Pre-clinical MASLD Mouse Model Development today from 12:55 PM to 2:55 PM. #MBSJ2024 #Proteinresearch #Cellbiology #Biotech #Innovation #MouseModels #CRO